Verona Pharma Share Discussion Threads

[goggin] 08/9/2020 09:51

In Trump world, if this has a sniff of success, then it will come to market and that will be the que for forward momentum. £7 within 2 years and who knows what after that - VRP vs Bleech ha ha, which one do you think will get approval to treat covid-19?

[haff1] 08/9/2020 09:23

ha ha...lets wait and see. Ive been here since around 2006.... I hope its a success but seen the share price go up then slowly fall time and time again.......This time I hope I'm wrong but not yet holding my breath....

[ny boy] 08/9/2020 08:39

NO sign of haff1, he must of gone off in a right haff after this mornings rns lol

[joeblogg2] 08/9/2020 08:28

From lse board:
Imo this will be brought to market quickly if successful, i discern the indicator clue is in the ceo statement....

"If the pilot study is successful, we are committed to progressing ensifentrine as a treatment for COVID-19 and, if approved, increasing supplies to meet public health needs.”

[joeblogg2] 08/9/2020 08:22

Finally working on covid-19 and do think Ensifentrine has huge potential to help covid as wel all thought!!!

[haff1] 01/9/2020 17:37

..this really is a dissapointing and miserable little stock!

[haff1] 26/8/2020 20:25

...... shares as insentive for doing what exactly? Just being there? Its discusting this riping off shareholders money so that they get freebees? When are they actually going to get this up and running? If by May 2021 we havent got a large pharma securely signed up to fund this going forward are they going to give those shares back!!!?

[shakin not stirred] 25/8/2020 23:12

Good to see a bit of BLUE. Is a partnership deal possible this year.... possible. But if successful covid trials it becomes a whole lot more probable and big jump in SP

[haff1] 21/8/2020 11:50

Usual jam tomorrow drop back to where it was....It would be good to see this actually go up and hold for once. If it has the potential claimed isn't it about time some larger company was taking a serious interest? ....but it doesnt seem to be!

[shakin not stirred] 19/8/2020 09:17

typo 12 should be 6. I hasten to add that if they had been on the ball. The placing would have happened at £1 to £2 and not 45p.When will the board start to be a bit more proactive and intelligent in their decisions Extra dilution for us share holders. They would think twice if they ever actually bought lots of shares but alas that is something that only our chairman has done. Sums up the company unfortunately as they continue to stumble like a punch drunk boxer. Maybe this new CEO will turn it around as he has been handsomely paid already.

[shakin not stirred] 19/8/2020 09:10

Bonzo covid 19 treatment opportunity was 12 months ago.They have never that I can recall made the correct decision. However the wind of fortune has to change at some point. With all the news due this should be £1.50- £2. But this is VRP after all.

[ny boy] 17/8/2020 09:33

Just up, stay & hold for a year or two imho

[bewise2] 17/8/2020 09:19

Back to the £1.50s + :)

[pjm1162] 14/8/2020 17:08

70'sBack to 40's soon

[tradertrev] 14/8/2020 09:09

...after a visit to the 90's

[goggin] 14/8/2020 07:12

I am also pleased to announce that we have received a notice to proceed for our Investigational New Drug ("IND") from the FDA to study ensifentrine in patients with COVID-19. We plan to initiate a randomized, double-blind, placebo-controlled pilot clinical study to evaluate ensifentrine delivered via pressurized metered-dose inhaler ("pMDI") formulation as a treatment for patients hospitalized with COVID-19 at the University of Alabama at Birmingham. Clinical data from prior studies of ensifentrine in other respiratory diseases have demonstrated ensifentrine improves lung function and reduces cellular markers of inflammation in the lungs. We believe ensifentrine, with its novel mechanism of action, has the potential to improve oxygenation and lung function assisting recovery from COVID-19.

[bonzo] 14/8/2020 07:07

Now here's an idea. An inhaler treatment for early stage COVID. That would be amazing...

[bonzo] 14/8/2020 07:04

Glad to see they have woken up to the COVID treatment opportunity. This is a much bigger market opp than COPD and the drug should work well...

[shakin not stirred] 13/8/2020 17:50

Dr R
potentially looks like you may have.Does not seem to long before we get to the 45p placement share price Yes Timbo has good posts and sold up a chunck I believe when they missed a golden opportunity.
I hasten to add that the Uk management received riduculously high renumeration for what little they achieved during their failed reign.However in balance the USA management have in the short time received even more renumeration for doing nothing so far. Other than a placing at no premium, yet they say we have a premium product. Dr Z has been awarded 3% of the company shares and it appears that we are left with a very poor percentage of the funding. That must have some seriously large admin and arrangement fees that I have ever seen.I would like to see the company accounts and the auditors allocation of costs for that onein year end accounts which I Will scrutinise with the eye of an eagle and ask any relevant questions at the next AGM.

[drradcliffe] 13/8/2020 16:18

I hope by posting I haven't hastened its move down to 45p!!

[drradcliffe] 13/8/2020 15:08

There is so much bad history here. I've lost most times I have bought and sold this over the years. It's now essentially a US company. Previous UK management have drawn significant salaries and options and haven't progressed development nearly as much as they should have done.

But, one day it could easily come good. It's a bit of a "horse racing" type share. It could go down to the 45p placement price, it's pretty illiquid. Shares like this are volatile. But they are just about to enter phase 3 and have a decent number of life science funds invested.

Anyone thinking of investing should look at the August presentation, read some of the previous posts (Timbo's are always good) and weigh up the odds.

[shakin not stirred] 13/8/2020 14:36

tom greg. Not anymore. Back to the PLACING share price Sell high which is now and the buy low placing. No news for a very long time as sweet FA happening here as per usual.

[shakin not stirred] 12/8/2020 00:04

Well Timbo you will probably be purchasing more as the price has only been worked higher so those in the latest fund raise can exit hence the big price drop in the USA today. The Yanks will eventually cotton on to the pattern that this share price follows. Sell high and buy low. This is to be traded to get any money from your investment.I too will top up at placement price.When we have lost so many chief medical officers it really tells the true picture. The share price even at £1 should be lunacy but so often the market has it correct more often than the investors and the share price is where it is due to poor direction and lost opportunities. This company is great if you are on the payroll otherwise totally uninspiring in all they do. Glad you are still about Timbo. Expecting that we will both get the chance to top up below the placing price this side of Christmas.

[timbo003] 11/8/2020 15:03

Shakin'

No, I am still here and invested, but I am not inclined to buy any more right now, if they drift back to the placing price, I may be tempted.

I think the management did lose their way focusing on the DPI and MDI formats a while back, however reading between the lines of the funding RNS, it seems they are now concentrating on the nebulized (single active) solution, which IMO they should have done all along.

For what it's worth I do not think it will ever be sold as a combo with a LABA or LAMA as the duration of action seems to be around 6 hours which is insufficient to combine with other actives which have a duration of action of 10 - 12 hours.